$92.72
$0.00 (0.00%)
End-of-day quote: 05/04/2024
NasdaqGS:BNTX
BioNTech Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $149.27 | $174.55 | 0.00% | 3 | $359.25B |
| MRK | Merck | NYSE | Outperform | $127.51 | $130.51 | 0.00% | 11 | $322.99B |
| AZN | AstraZeneca PLC | LSE | Outperform | £120.50 | £165.99 | 0.00% | 16 | £186.80B |
| PFE | Pfizer | NYSE | Outperform | $27.81 | $32.87 | 0.00% | 6 | $157.48B |
| SAN | Sanofi | ENXTPA | Outperform | 91.30€ | 102.80€ | 0.00% | 9 | 114.00€B |
| GSK | GSK | LSE | Outperform | £17.34 | £17.30 | 0.00% | 12 | £70.69B |
| MRNA | Moderna | NasdaqGS | Outperform | $125.00 | $135.42 | 0.00% | 1 | $47.90B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.47T |
| LONN | Lonza Group | SWX | Buy | CHF519.60 | CHF516.89 | 0.00% | 8 | CHF37.47B |
| NVAX | Novavax | NasdaqGS | Outperform | $4.93 | $23.25 | 0.00% | 4 | $603.61M |
| CVAC | CureVac N.V. | NasdaqGM | Outperform | $3.13 | $12.92 | 0.00% | 1 | $564.45M |
| VLA | Valneva | ENXTPA | Outperform | 3.43€ | 9.32€ | 0.00% | 0 | 469.10€M |
| VBIV | VBI Vaccines | NasdaqCM | Outperform | $0.59 | $6.00 | 0.00% | 0 | $18.02M |
